biovision nec 1s

potent necroptosis inhibitor biovision nec 1s

Product Details:

Alternate Name5-((7-Cl-1H-indol-3-yl)methyl)-3-methylimidazolidine-2,4-dione); 7-Cl-O-Nec-1
Peptide SequenceNo
AppearanceYellow solid
CAS #852391-15-2
Molecular FormulaC₁₃H₁₂ClN₃O₂
Molecular Weight277.71
Purity≥96% by TLC and LC-MS
SolubilityDMSO
SMILESCN1C(=O)C(NC1=O)CC2=CNC3=C2C=CC=C3Cl
InChiInChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19)
InChi KeyWIKGAEMMNQTUGL-UHFFFAOYSA-N
PubChem CID643953
HandlingProtect from light and moisture
Storage Conditions-20°C
Shipping ConditionsGel Pack
USAGEFor Research Use Only! Not For Use in Humans.
biovision nec 1s

biovision nec 1s

 

Descriptions:

A potent necroptosis inhibitor. Displays higher activity in inhibiting necroptosis in Jurkat cells than Nec-1 (Cat. No. 1864) (EC₅₀ = 210 nM versus EC₅₀ = 490 nM), as well as showing no nonspecific cytotoxicity at high concentrations (~100 mM). More useful for in-cell and in vivo experiments compared to Nec-1.

Abstract
Abdominal aortic aneurysm (AAA) is a common aortic disease with a progressive nature. There is no approved pharmacological treatment that would effectively slow the growth of the aneurysm or prevent rupture. Necrosis is a form of programmed necrosis that is regulated by receptor-interacting protein kinases (RIPs). We have recently shown that a lack of RIP3 in mice prevented aneurysm formation.

The mean aortic diameter of Nec-1-treated mice appeared to be smaller (121.60 ± 10.40%) than the DMSO group, although the difference was not statistically significant (P = 0.1). Histologically, the aortic structure of Nec-1s-treated mice appeared normal, with continuous and organized elastin layers and rich SMCs expressing αActin.

In addition, Nect-1 treatment reduced macrophage infiltration and MMP9 accumulation and increased tropoelastin and lysyl oxidase aortic levels. Together, our data suggest that pharmacological inhibition of necrosis by Nec-1 stabilizes pre-existing aneurysms by reducing inflammation and promoting connective tissue repair.

 

IQ-1S

abx282388-20g 20 µg
EUR 118.75

IQ-1S

abx282388-50g 50 µg
EUR 225

IQ-1S

B1279-25 each
EUR 548.4

IQ-1S

B1279-5 each
EUR 183.6

MM.1S

CSC-C9219W One Frozen vial Ask for price
Description: Leukemia - Lymphoma - Myeloma Cells

(1S)-Camphorsultam

C175125 1g
EUR 224
  • C₁₀H₁₇NO₂S
Description: 94594-90-8

IQ-1S

MBS131364-100mg 100mg
EUR 1495

(1S)-Calcitriol

HY-10002A 1 mg
EUR 1623.4
Description: (1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3) is a natural metabolite of 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3). (1S)-Calcitriol exhibits potent vitamin D receptor (VDR)-mediated actions such as inhibition of keratinocyte growth or suppression of parathyroid hormone secretion[1].

(1S)-(+)-Myrtenol

M125410 100mg
EUR 621
  • C₁₀H₁₆O
Description: 6712-78-3

IQ-1S

MBS3603652-100mg 100mg
EUR 475

IQ-1S

MBS3603652-10mg 10mg
EUR 215

IQ-1S

MBS3603652-25mg 25mg
EUR 265

IQ-1S

MBS3603652-50mg 50mg
EUR 330

IQ-1S

MBS3603652-5mg 5mg
EUR 200

IQ-1S

MBS384929-10mg 10mg
EUR 160

IQ-1S

MBS384929-25mg 25mg
EUR 230

IQ-1S

MBS384929-50mg 50mg
EUR 330

IQ-1S

MBS384929-5x50mg 5x50mg
EUR 1480

(1S)-Chrysanthemolactone

MBS5761290-1mg 1mg
EUR 180

(1S)-Chrysanthemolactone

MBS5761290-5x1mg 5x1mg
EUR 655

IQ-1S

MBS516401-25mg 25mg
EUR 375

IQ-1S

MBS516401-5mg 5mg
EUR 205

IQ-1S

MBS516401-5x25mg 5x25mg
EUR 1440

(1S)-Camphorsultam

MBS6114899-1g 1(g
EUR 485

(1S)-Camphorsultam

MBS6114899-5x1g 5x1g
EUR 2025

IQ-1S

MBS578494-100mg 100mg
EUR 345

IQ-1S

MBS578494-10mg 10mg
EUR 145

IQ-1S

MBS578494-25mg 25mg
EUR 180

IQ-1S

MBS578494-50mg 50mg
EUR 240

IQ-1S

MBS578494-5mg 5mg
EUR 145

(1S)-Calcitriol

MBS5796866-1mg 1(mg
EUR 1480